Find out more about how you can promote your products at the vaccines sector’s premier event by downloading the sponsorship brochure today.
“The excellent program, the quality of the speakers and their relevance for the field. In terms of commercial opportunities, the former provides an opportunity to engage with the relevant leader.”
“Great networking opportunity and the level of technical talks is well targeted”
“Well organised, interesting sessions, high calibre attendees supporting good networking opportunities”
The development of a new vaccine is a complex venture. Biotech and pharmaceutical companies are increasingly choosing to outsource their manufacturing efforts, as partnering with the right CMO can streamline this process. Since 2011, total global spending on contract manufacturing reached $31.9 billion according to a 2012 industry report entitled, “The CMO Market Outlook to […]
Positive Lot-to-Lot Consistency Data Pave Way for Biologics License Application (BLA) Submission in 2015 December 8, 2014 PaxVax Inc., a specialty vaccine company focused on travel and biodefense, today announced positive results from a Phase 3 safety and lot-to-lot consistency trial of its single-dose oral cholera vaccine candidate, PXVX0200, which utilizes the same attenuated vaccine […]
The post PaxVax Announces Primary Endpoints Met in Phase 3 Cholera Vaccine Trial appeared first on Vaccine Nation.
Sites in Europe and Asia add to patient enrollment and position Company to apply for global regulatory approvals December 8, 2014 CEL-SCI Corporation today announced that during November it has added seven new clinical sites to its global pivotal Phase III head and neck cancer trial for its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). Patient screening […]
Strategy and innovation in vaccines